NCT05113238

Brief Summary

This study will be conducted to compare two different Assisted Gamete treatment (AGT) with oocyte-sibling-split design control group : AGT- initial protocol for activating oocytes by culturing oocytes in calcium ionophore after injection for two rounds of 10 minutes at 37 C, 30 minutes after injection. sample group : AGT-revised protocol oocytes will be injected by sperm previously cultured in Ca ionophore and 0.4 pL of calcium ionophore then will be cultured in calcium ionophore after injection for 10 minutes

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
222

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 8, 2021

Completed
7 days until next milestone

Study Start

First participant enrolled

October 15, 2021

Completed
25 days until next milestone

First Posted

Study publicly available on registry

November 9, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2021

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
Last Updated

September 21, 2022

Status Verified

September 1, 2022

Enrollment Period

2 months

First QC Date

October 8, 2021

Last Update Submit

September 18, 2022

Conditions

Keywords

Calcium ionophoregamete activationICSImale factor

Outcome Measures

Primary Outcomes (3)

  • Number of top quality day 3 embryos

    number of top quality embryos

    3 days after ICSI procedure day

  • Number of Top quality day 4 embryos

    number of top quality embryos

    4 days after ICSI procedure

  • Number of Top quality day 5 embryos

    number of top quality embryos

    5 days after ICSI procedure

Secondary Outcomes (1)

  • chemical pregnancy rate

    15 days after embryo transfer procedure day

Study Arms (2)

AGT-Initial

ACTIVE COMPARATOR

Oocytes will be injected with spermatozoa and will be incubated in 10 mM calcium ionophore (Sigma-Aldrich) for two rounds of 10 minutes at 37 C, 30 minutes after ICSI injection, and then will be rinsed and transferred into culture medium.

Procedure: Assisted gamete activation

AGT-revised

EXPERIMENTAL

ejaculated spermatozoa will be exposed to calcium ionophore in a drop on the ICSI dish before injection. During the ICSI procedure, spermatozoa will be aspirated individually from the drop containing calcium ionophore and immobilized in a separate PVP drop. Next, approximately 0.4 pL of calcium ionophore will be aspirated into the micropipette and injected into the oocyte with the spermatozoa. Post-ICSI oocytes will be then exposed to 50 mM calcium ionophore for 10 minutes at 37C, and then will be washed and placed in culture medium.

Procedure: Assisted gamete activation

Interventions

compare two different assisted gamete activation protocols to improve ICSI outcome

AGT-InitialAGT-revised

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • couples presented with an extremely poor fertilization (\<10%)
  • couples with previous complete fertilization failure after undergoing ICSI cycles
  • At least 4 MII oocytes
  • Severe oligoasthinozoospermia
  • Teratozoospermia
  • testicular aspirated sperm

You may not qualify if:

  • age \>40 years
  • BMI \>34
  • aspirated oocytes \< 4
  • Normozoospermia
  • subfertile patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Fertility Center

Al Mansurah, Daqahlya, 35511, Egypt

Location

Study Officials

  • Sahar SA Eissa, PHD

    research team leader

    STUDY DIRECTOR
  • Engy EA Abdallah, M.sc

    investigator & researcher

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: single group of patients will be conducted into sibling-oocyte-split design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2021

First Posted

November 9, 2021

Study Start

October 15, 2021

Primary Completion

December 25, 2021

Study Completion

December 30, 2021

Last Updated

September 21, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will share

study protocol and outcome

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Time Frame
two months

Locations